Axil Capital is a Tokyo-based venture capital firm focused on biomedical and healthcare technology. It backs life sciences companies from seed through crossover and later-stage venture rounds, including biotechnology, platform technologies, medical devices, digital health, pharmaceuticals and healthcare services, with a focus on Japan and global markets including the United States and Taiwan.